Proceedings in Obstetrics and Gynecology
Not a member yet
462 research outputs found
Sort by
Division of Maternal-Fetal Medicine
Get PDFThe Division of Maternal-Fetal Medicine presently includes six board certified maternal-fetal specialists. They are: Kimberly K. Leslie, MD (Department Head), Stephen K. Hunter, MD, PhD., (Division Director), Jennifer R. Niebyl, MD, Asha Rijhsinghani, MD, Kristi Borowski, MD, and Mark Santillan, MD. Dr. Roger A. Williamson, double boarded in Genetics and Obstetrics, is also an Emeritus member of the Division
Towards increasing health care in the developing world: development of a sustainable site in Bolivia
Get PDFMost Americans are aware of the great need for health care services in the developing world. In this article, Dr. Thomas Gellhaus provides a compelling story of his volunteer efforts to provide obstetric/gynecologic surgical services to developing countries. Since 1996, he has completed 16 projects in the Dominican Republican, Ecuador, Peru, Bolivia, and Tanzania. In direct response to Dr. Gellhaus’ successes, the Department of Obstetrics and Gynecology at the University of Iowa has made a commitment to develop a sustainable site in Bolivia. Current plans include annual projects that allow physicians and residents to provide valuable medical care to patients in Bolivia, and the long-term vision is to develop an infrastructure that improves health care in this population
Lymphoid Enhancing Factor 1 (Lef-1) overexpression in epithelial ovarian, fallopian tube and peritoneal cancer and associations with clinical factors
Get PDFLef-1 mRNA levels were statistically elevated in cases of ovarian, fallopian tube or peritoneal cancer when compared to non-cancerous controls. Among cancer cases, levels of Lef-1 were statistically different between stage and histology. Lef-1 overexpression may be predictive of poor overall survival. These findings suggest that Lef-1 overexpression may contribute to ovarian, fallopian tube and peritoneal carcinogenesis, and that further investigation is warranted
Comparison of P53 mutation status, primary cytoreductive surgical outcomes, and overall survival in patients with ovarian cancer
Get PDFOptimal surgical cytoreduction continues to be an important prognostic variable in patients with ovarian cancer independent of p53 mutational status. Among patients with suboptimal cytoreduction a p53 mutation may offer a survival advantage